Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07044557 · ClinicalTrials.gov registry record · NA
MeDex: No Perioperative Dexamethasone in Brain Metastases
A NA study of Brain Metastases, sponsored by University of Louisville.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT07044557: Recruiting NA study of Brain Metastases, sponsored by University of Louisville.
NCT07044557 is a NA study of Brain Metastases that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 35 participants, below the 212-participant average among 67 other Brain Metastases trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07044557, a NA study of Brain Metastases, is actively recruiting participants, sponsored by University of Louisville.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
Perioperative treatment of newly diagnosed cancer patients with brain metastasis without dexamethasone (Dex).
Primary Outcome
Initiation of dexamethasone after enrollment up to 3 weeks after surgery.
Conditions Studied
Interventions
- OTHER Withholding perioperative Dexamethasone
Study Locations (1)
Kentucky
- University of Louisville Hospital - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2025-12-03 |
| Est. Completion | 2027-10 |
| Phase | NA |
What NCT07044557 shows while recruiting
NCT07044557 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 212-participant average among 67 other Brain Metastases trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Brain Metastases appearing as the primary indexed condition, and to 1 intervention - of which Withholding perioperative Dexamethasone is the first listed.
NCT07044557 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT07044557 about?
NCT07044557 is a clinical study titled "MeDex: No Perioperative Dexamethasone in Brain Metastases". Perioperative treatment of newly diagnosed cancer patients with brain metastasis without dexamethasone (Dex).
What is the current status of trial NCT07044557?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2025-12-03. Estimated completion is 2027-10.
What conditions does trial NCT07044557 study?
This clinical trial studies the following conditions: Brain Metastases.
What interventions are being tested in trial NCT07044557?
The interventions under investigation include: Withholding perioperative Dexamethasone (OTHER).
Who is sponsoring clinical trial NCT07044557?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07044557 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07044557's enrollment target sits among peer trials
35 40th of 67 higher than 28 of 67 other Brain Metastases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Metastases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trial of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases
RECRUITING · NA
-
Evaluation of the CONVIVO System
RECRUITING · NA
-
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
RECRUITING · NA
-
REMASTer: REcurrent Brain Metastases After SRS Trial
RECRUITING · NA
-
Development of MRF for Characterization of Brain Tumors After Radiotherapy
RECRUITING · NA
-
A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI